![Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia | Technology Networks Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia | Technology Networks](https://assets.technologynetworks.com/production/dynamic/images/content/328237/antibody-enters-clinical-trial-for-treatment-of-b-cell-acute-lymphoblastic-leukemia-328237-1280x720.jpg?cb=10488061)
Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia | Technology Networks
![Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia - The Journal of Pediatrics Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia - The Journal of Pediatrics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c3c6a8a1-7ab6-4bbf-8c59-31fe84f34ebd/ympd10133-fig-0002_lrg.jpg)
Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia - The Journal of Pediatrics
![Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07 | Blood Cancer Journal Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07 | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-00383-2/MediaObjects/41408_2020_383_Fig1_HTML.png)
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07 | Blood Cancer Journal
![A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial - The Lancet A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fb46a282-36c8-4ce7-bc94-244aebc1ad07/gr1_lrg.jpg)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial - The Lancet
![Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial - The Lancet Oncology Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/2c49baf5-0028-4d19-a47f-1ca99bf98c9d/gr1.jpg)
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial - The Lancet Oncology
![Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial - The Lancet Haematology Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial - The Lancet Haematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cdb34713-e0b9-4d14-9810-4851e5589d59/gr1.gif)
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial - The Lancet Haematology
![Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/39806e6b-ee3b-4ac4-8366-faf3ce15d145/gr1_lrg.jpg)
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation
![CLINICAL TRIALS AND OBSERVATIONS Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene–rearranged acute lymphoblastic leukemia CLINICAL TRIALS AND OBSERVATIONS Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene–rearranged acute lymphoblastic leukemia](https://ars.els-cdn.com/content/image/1-s2.0-S2473952921005292-grabsf1.jpg)
CLINICAL TRIALS AND OBSERVATIONS Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene–rearranged acute lymphoblastic leukemia
![Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia | Bone Marrow Transplantation Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-021-01253-6/MediaObjects/41409_2021_1253_Fig1_HTML.png)
Non-inferior long-term outcomes of adults with Philadelphia chromosome-like acute lymphoblastic leukemia | Bone Marrow Transplantation
![Recent advances on blinatumomab for acute lymphoblastic leukemia | Experimental Hematology & Oncology | Full Text Recent advances on blinatumomab for acute lymphoblastic leukemia | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40164-019-0152-y/MediaObjects/40164_2019_152_Fig1_HTML.png)
Recent advances on blinatumomab for acute lymphoblastic leukemia | Experimental Hematology & Oncology | Full Text
![Development timeline of blinatumomab for the treatment of B-cell acute... | Download Scientific Diagram Development timeline of blinatumomab for the treatment of B-cell acute... | Download Scientific Diagram](https://www.researchgate.net/publication/328010027/figure/fig2/AS:677083453870080@1538440683256/Development-timeline-of-blinatumomab-for-the-treatment-of-B-cell-acute-lymphoblastic.png)
Development timeline of blinatumomab for the treatment of B-cell acute... | Download Scientific Diagram
![Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan | Scientific Reports Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-85213-6/MediaObjects/41598_2021_85213_Fig1_HTML.png)
Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan | Scientific Reports
![Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4e1ab882-7ce3-429b-9c95-4bc18ce95b7b/gr1.jpg)
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Selected clinical trials of CAR T cells in B-cell acute lymphoblastic... | Download Scientific Diagram Selected clinical trials of CAR T cells in B-cell acute lymphoblastic... | Download Scientific Diagram](https://www.researchgate.net/publication/341319429/figure/tbl1/AS:890352726732802@1589288040223/Selected-clinical-trials-of-CAR-T-cells-in-B-cell-acute-lymphoblastic-leukemia_Q640.jpg)